Rosenthal Miriam D, Albrecht Eugene D, Pepe Gerald J
Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA 23501-1980, USA.
Endocrine. 2004 Mar-Apr;23(2-3):219-28. doi: 10.1385/ENDO:23:2-3:219.
Although estrogen plays a central integrative role in regulating key aspects of placental and fetal endocrine development in the primate, our understanding of the regulation of maturation of the fetal liver is incomplete. In adults, estrogen modulates several aspects of hepatic function. Therefore, the current study determined whether fetal hepatic gene expression development was modulated by estrogen. mRNA differential display was used to identify genes whose expression was altered in fetal livers obtained on d 165 of gestation (term = d 184) from baboons that were untreated or treated on d 60-164 with the aromatase inhibitor CGS 20267 (2 mg/d; sc), which suppressed estrogen levels in the fetus by >95% (p < 0.01). As confirmed by Northern blot, the mRNA levels (ratio to 18s RNA) of metallothionein I (MT-I), porphobilinogen deaminase (PBG-D), and cytochrome P450 2C8 (CYP 2C8) in the livers of estrogen-deprived fetuses were 5-, 12-, and 3-fold higher (p < 0.05) than respective values of untreated fetuses. Moreover, mRNA levels of MT-I and PBG-D, expressed as a ratio to 18s RNA, were 3-fold and 26-fold higher (p < 0.05) on d 60-100 of gestation than on d 165 and in the adult. In contrast, CYP 2C8 mRNA increased 10-fold between d 100 and 165 and was not further altered in adult liver. Immunohistochemistry confirmed expression of MT-I in hepatocytes. Erythropoietic cells, normally present in the fetal baboon liver on d 100 but not on d 165, were also detected on d 165 in animals treated with the aromatase inhibitor. Thus, upregulation of PBG-D mRNA in estrogen-deprived baboons may reflect prolongation of the erythropoietic role of the fetal liver. In summary, these results indicate that the normal developmental change in MT-I, PBG-D, and CYP 2C8 mRNA expression in baboon fetal liver with advancing gestation are dependent on increased secretion of estrogen into the fetus. We suggest, therefore, that estrogen regulates normal development of the primate fetal liver.
虽然雌激素在调节灵长类动物胎盘和胎儿内分泌发育的关键方面发挥着核心整合作用,但我们对胎儿肝脏成熟调节的理解并不完整。在成年人中,雌激素调节肝脏功能的多个方面。因此,当前研究确定胎儿肝脏基因表达的发育是否受雌激素调节。采用mRNA差异显示技术来鉴定那些在妊娠165天(足月为184天)从狒狒获取的胎儿肝脏中表达发生改变的基因,这些狒狒在妊娠60 - 164天未接受处理或接受了芳香化酶抑制剂CGS 20267(2毫克/天;皮下注射)的处理,该抑制剂使胎儿体内雌激素水平降低了95%以上(p < 0.01)。经Northern印迹法证实,雌激素缺乏胎儿肝脏中金属硫蛋白I(MT - I)、胆色素原脱氨酶(PBG - D)和细胞色素P450 2C8(CYP 2C8)的mRNA水平(与18s RNA的比值)分别比未处理胎儿的相应值高5倍、12倍和3倍(p < 0.05)。此外,以与18s RNA的比值表示,MT - I和PBG - D的mRNA水平在妊娠60 - 100天时比在165天时及成年时分别高3倍和26倍(p < 0.05)。相反,CYP 2C8 mRNA在100天至165天之间增加了10倍,在成年肝脏中未进一步改变。免疫组织化学证实MT - I在肝细胞中表达。在妊娠100天时正常存在于狒狒胎儿肝脏中但在165天时不存在的红细胞生成细胞,在接受芳香化酶抑制剂处理的动物的165天时也被检测到。因此,雌激素缺乏的狒狒中PBG - D mRNA的上调可能反映了胎儿肝脏红细胞生成作用的延长。总之,这些结果表明狒狒胎儿肝脏中MT - I、PBG - D和CYP 2C8 mRNA表达随妊娠进展的正常发育变化依赖于胎儿体内雌激素分泌的增加。因此,我们认为雌激素调节灵长类胎儿肝脏的正常发育。